{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:34:37Z","timestamp":1770428077128,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>\n            Acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely consumed. Each is theoretically capable of elevating blood pressure by altering prostaglandin homeostasis; however, there is little prospective information on the relation between these agents and physician-diagnosed hypertension. We examined the association between the use of aspirin, acetaminophen, or NSAIDs and incident hypertension in a prospective cohort study of 51 630 women 44 to 69 years of age in 1990 who had no history of hypertension or chronic renal insufficiency. Analgesic use was assessed in 1990 by a mailed questionnaire, and the women were followed for 8 years. The primary outcome was physician-diagnosed hypertension reported on a follow-up biennial questionnaire. During 381 078 person-years of follow-up, 10 579 incident cases of hypertension were identified. Compared with nonusers, women who used aspirin or acetaminophen at least 1 day per month or NSAIDs 5 or more days per month were at a significantly higher risk for development of hypertension. After adjusting for potential confounders, the odds ratios for women in the highest frequency of use category (\u226522 days per month) compared with no use were as follows: aspirin, 1.21 (95% CI, 1.13 to 1.30); acetaminophen, 1.20 (1.08 to 1.33); and NSAIDs, 1.35 (1.25 to 1.46). For each analgesic type, there was a significant trend toward an increased risk of incident hypertension with increasing frequency of use (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001). Given the observed odds ratios, biologic plausibility, and the sizeable population at risk, health professionals should consider potential hypertensive effects of aspirin, acetaminophen, and NSAIDs when counseling their patients about the use of nonnarcotic analgesics.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000035856.77718.da","type":"journal-article","created":{"date-parts":[[2002,10,31]],"date-time":"2002-10-31T22:49:12Z","timestamp":1036104552000},"page":"604-608","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":105,"title":["Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women"],"prefix":"10.1161","volume":"40","author":[{"given":"Julien","family":"Dedier","sequence":"first","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir J.","family":"Stampfer","sequence":"additional","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter C.","family":"Willett","sequence":"additional","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Speizer","sequence":"additional","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary C.","family":"Curhan","sequence":"additional","affiliation":[{"name":"From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","first-page":"S60.","volume":"9","year":"2000","unstructured":"Kaufman DW, Kelly JP, Anderson TE, Rosenberg L, Mitchell AA. A comprehensive population-based survey of medication use in the United States: the adult population. Pharmacoepidemiol Drug Saf. 2000; 9: S60.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410040045007"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00011"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520100043031"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(78)90378-1"},{"key":"e_1_3_3_6_2","first-page":"405","volume":"210","year":"1979","unstructured":"Mattammal MB, Zenser TV, Brown WW, Herman CA, Davis BB. Mechanism of inhibition of renal prostaglandin production by acetaminophen. J Pharmacol Exp Ther. 1979; 210: 405\u2013409.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.8.3073"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01478209"},{"key":"e_1_3_3_9_2","first-page":"1077","volume":"6","year":"1984","unstructured":"Chalmers JP, West MJ, Wing LM, Bune AJ, Graham JR. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens [A]. 1984; 6: 1077\u20131093.","journal-title":"Clin Exp Hypertens [A]"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Curhan G Willett WC Rosner B Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med. 2002. In press.","DOI":"10.1001\/archinte.162.19.2204"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.3.305"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90878-9"},{"key":"e_1_3_3_13_2","first-page":"40","volume":"50","year":"1995","unstructured":"Colditz GA. The nurses\u2019 health study: a cohort of US women followed since 1976. J Am Med Womens Assoc. 1995; 50: 40\u201344.","journal-title":"J Am Med Womens Assoc"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114319"},{"key":"e_1_3_3_15_2","first-page":"S57","volume":"25","year":"1988","unstructured":"Cinotti GA, Pugliese F. Prostaglandins in blood pressure regulation. Kidney Int Suppl. 1988; 25: S57\u2013S60.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(96)90020-4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1978.tb06097.x"},{"key":"e_1_3_3_18_2","first-page":"927","volume":"271","year":"1994","unstructured":"Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases- 1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994; 271: 927\u2013934.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402023100502"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-154-39653"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108733"},{"key":"e_1_3_3_22_2","first-page":"453","volume":"188","year":"1974","unstructured":"Needleman P, Douglas JR Jr, Jakschik B, Stoecklein PB, Johnson EM Jr. Release of renal prostaglandin by catecholamines: relationship to renal endocrine function. J Pharmacol Exp Ther. 1974; 188: 453\u2013460.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_23_2","first-page":"257","volume":"10","year":"1996","unstructured":"Johnson AG, Nguyen TV, Owe-Young R, Williamson DJ, Day RO. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1. J Hum Hypertens. 1996; 10: 257\u2013261.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/48.3.M91"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb04169.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101173240304"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000035856.77718.DA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:52:51Z","timestamp":1715532771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000035856.77718.DA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1161\/01.HYP.0000035856.77718.DA"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000035856.77718.da","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2002-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}